Medulloblastoma: a potpourri of distinct entities

Pfister, Stefan
April 2012
Acta Neuropathologica;Apr2012, Vol. 123 Issue 4, p463
Academic Journal
An introduction is presented in which the author discusses various reports within the issue on topics including the classification of World Health Organization (WHO) to central nervous system (CNS) tumors, medulloblastoma gene expression, and sonic hedgehog (SHH)-driven medulloblastoma.


Related Articles

  • A prognostic analysis of pediatrics central nervous system small cell tumors: evaluation of EGFR family gene amplification and overexpression. Weidong Liu; Shigang Zhang; Liyong Zhang; Qingke Cui; Jiyue Wang; Ting Gui; Qi Pang // Diagnostic Pathology;2014, Vol. 9 Issue 1, preceding p1 

    Background Central nervous system (CNS) tumors are the most common solid tumors that occur in children, however there were few big-data follow-up analysis published in China. Overexpression of epidermal growth factor receptor (EGFR) family members was reported on glioblastoma (GBM) and...

  • ASPM gene expression in medulloblastoma. Vulcani-Freitas, Tânia M.; Saba-Silva, Najsla; Cappellano, Andréa; Cavalheiro, Sérgio; Marie, Sueli K. N.; Oba-Shinjo, Sueli M.; Malheiros, Suzana M. F.; de Toledo, Sílvia Regina Caminda // Child's Nervous System;Jan2011, Vol. 27 Issue 1, p71 

    Purpose: Medulloblastomas are the most common malignant tumors of the central nervous system in childhood. The incidence is about 19-20% between children younger than 16 years old with peak incidence between 4 and 7 years. Despite its sensibility to no specific therapeutic means like...

  • Stratification of medulloblastoma on the basis of histopathological grading. Giangaspero, Felice; Wellek, Stefan; Masuoka, Jun; Gessi, Marco; Kleihues, Paul; Ohgaki, Hiroko // Acta Neuropathologica;Jul2006, Vol. 112 Issue 1, p5 

    Medulloblastoma (WHO grade IV) is an embryonal tumour of the cerebellum and the most common malignant central nervous system tumour in children. Despite significant advances in treatment, 5-year survival rates are still less than 70%, suggesting the presence of subgroups with different response...

  • Mass biological profiling of cns tumours: Is it possible in india? Ray, A.; Buffet, E.; Rutka, J. T.; Hawkins, C. // Journal of Pediatric Neurosciences;Jul-Dec2007, Vol. 2 Issue 2, p102 

    INTRODUCTION: Biological profiling of tumours to predict outcome is gaining increasing popularity in the western world. The paucity of equipment and the prohibitive costs have meant that such profiling has not been universally popular especially in the developing world. This paper tries to...

  • Histologically defined central nervous system primitive neuro-ectodermal tumours (CNS-PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour types. Schwalbe, Ed. C.; Hayden, James T.; Rogers, Hazel A.; Miller, Suzanne; Lindsey, Janet C.; Hill, Rebecca M.; Nicholson, Sarah-Leigh; Kilday, John-Paul; Adamowicz-Brice, Martyna; Storer, Lisa; Jacques, Thomas S.; Robson, Keith; Lowe, Jim; Williamson, Daniel; Grundy, Richard G.; Bailey, Simon; Clifford, Steven C. // Acta Neuropathologica;Dec2013, Vol. 126 Issue 6, p943 

    The article presents a study which demonstrates the utility of DNA methylation profiling to show the distinction of pediatric brain tumour types including medulloblastomas, gliomas and ependymomas. The researchers have assessed the molecular and clinical characteristics of the central nervous...

  • Solid Tumours. Valteau, D.; Kalifa, C.; Grill, J.; Benhamou, E.; Hartmann, O.; Dallorso, S.; Rivabella, L.; Cefalo, G.; Milanaccio, C.; Porta, F.; Morreale, G.; Cappelli, B.; Garre, M.L.; Galaron, P.; Calvo, C.; Fernandez-Teijeiro, A.; Couselo, M.; Vivanco, J.L.; Cela, M.E. // Bone Marrow Transplantation;11/1/2002 Supplement, Vol. 30 Issue 9, pS31 

    Bone Marrow Transplantation (2002) 30, S31–S34. doi:10.1038/sj.bmt.1703746

  • The clinical experience of medulloblastoma treatment and the significance of time sequence for development of leptomeningeal metastasis. Po-Chuan Hsieh; Chieh-Tsai Wu; Kuang-Lin Lin; Tang-Her Jaing; Chen-Kan Tseng; Tai-Ngar Lui; Shih-Ming Jung // Child's Nervous System;Dec2008, Vol. 24 Issue 12, p1463 

    Among patients with medulloblastoma, an unrare aggressive central nervous system (CNS) tumor found mostly in the posterior fossa, drop metastasis from primary location to anatomically lower sites including whole spinal cord is known as a potential way for tumor to spread. There were already lots...

  • Pilocytic astrocytoma developing at the site of a previously treated medulloblastoma in a child. Koksal, Yavuz; Toy, Hatice; Unal, Ekrem; Baysal, Tamer; Esen, Hasan; Paksoy, Yahya; Ustun, M. Erkan // Child's Nervous System;Mar2008, Vol. 24 Issue 3, p289 

    Background After the achieved high cure rates, the survivors of medulloblastoma have come to face other complications associated with treatment regimes. One of these complications is secondary malignant neoplasm (SMN), which is rare but generally fatal. Case history We report a case of an...

  • AXIN-1 Protein Expression and Localization in Glioblastoma. Pećina-Šlaus, Nives; Martić, Tamara Nikuševa; Kokotović, Tomislav; Kušec, Vesna; Tomas, Davor; Hrašćan, Reno // Collegium Antropologicum;Mar2011 Supplement 1, Vol. 35, p101 

    The etiology and pathogenesis of tumors of the central nervous system are still inadequately explained. In the present study the expression patterns of a critical molecular component of wnt signaling pathway - axin 1 was investigated in 42 patients with glioblastoma, the most aggressive form of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics